Filing Flows › Core Scientific, Inc./tx (CORZ) › Q3 2025
Core Scientific, Inc./tx (CORZ) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 24, 2025
Core Scientific, Inc./tx (CORZ) reported revenue of $81.1M for the third quarter 2025 (Q3 2025), -15% from a year earlier and +3% from the quarter before. Operating margin was -67.6%, net loss $144M (177.6% of revenue).
Core Scientific, Inc./tx, Q3 2025: revenue $81.1M (-15% year over year), operating margin -67.6%, net loss $144M, operating cash flow $132M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $81.1M | +3% | -15% |
| Operating profit | −$54.8M | — | — |
| Net earnings | −$144M | — | — |
| Operating cash flow | $132M | +288% | 23× |
What changed
Revenue was $81.1M in Q3 2025, down 15% year over year and up 3% from the previous quarter.
Gross margin was 4.8%. Operating costs exceeded revenue by $54.8M, an operating margin of -67.6%. The quarter ended with a net loss of $144.0M, narrower than the previous quarter's $936.8M loss. Net interest and other expense of $89.1M was the main reason.
Operating cash flow was $131.8M (up 2207% year over year). Non-cash charges added back $16.3M of depreciation and amortization and $29.9M of share-based compensation. Working capital and other items added $229.5M. Capital expenditures of $244.5M exceeded it, leaving free cash flow of −$112.7M.
Questions
What was Core Scientific, Inc./tx's revenue in the third quarter 2025?
Core Scientific, Inc./tx (CORZ) reported revenue of $81.1M for the third quarter 2025 (Q3 2025), -15% from a year earlier and +3% from the quarter before.
Was Core Scientific, Inc./tx profitable in the third quarter 2025?
Operating loss was $54.8M (-67.6% of revenue) and net loss $144M.